Press Releases

10.8.24

Seattle Children’s has been recognized as one of the top 10 best children's hospitals in the U.S. and #1 in the Pacific region

3.28.24

One of the largest donations from an individual donor in its 117-year history

12.5.23

BrainChild Bio’s initial CAR T-cell therapy program will focus on advancing ongoing clinical trials evaluating safety and efficacy in pediatric brain tumors

10.3.23

Seattle Children’s and Heritage University are pleased to jointly announce a generous $4 million gift from Gaye and Jim Pigott to advance equity of the nursing workforce in Washington.

9.18.23

Dr. Vittorio Gallo appointed senior vice president and chief scientific officer.

11.1.22

The healthcare leader is recognized for best practices in sharing diversity data transparently

10.24.22

Jamie Phillips Appointed Seattle Children’s Senior Vice President and Chief Operating Officer

9.15.22

A Message From Seattle Children’s Executive Leadership Team

9.13.22

Dr. Eric Tham appointed senior vice president and chief research operations officer

7.19.22

Seattle Children’s and a network of children’s hospitals from across the country will coordinate on the response to future pandemics and other disasters through a new $29 million grant from the Health Resources and Services Administration (HRSA).

6.30.22

Seattle Children's Commitment to Sustainability Strengthens with Signing of HHS Health Care Sector Pledge

6.9.22

Today, Seattle Children’s is releasing the third Health Equity and Anti-Racism Action Plan quarterly report.

6.9.22

Researchers are seeking to recruit 3,500 children and adults in the Pacific Northwest to assess how well vaccines protect against COVID-19 infection.

5.5.22

Seattle Children’s announced the appointment of Dondi Cupp as its new senior vice president and chief development officer leading the Seattle Children’s Foundation and Guild Association effective June 2, 2022. Cupp joins Seattle Children’s from Oregon Health & Science University Foundation.

4.1.22

Fred Hutchinson Cancer Center is a unified adult cancer research and care center that is a clinically integrated part of UW Medicine

3.29.22

Seattle Children’s received an evaluation of 100 and the designation of “LGBTQ+ Healthcare Equality Leader” in the Human Rights Campaign Foundation’s Healthcare Equality Index (HEI).

3.10.22

Today, Seattle Children’s is releasing the second Health Equity and Anti-Racism Action Plan (Action Plan) quarterly report, an important milestone during a week where we also celebrate the opening of the OBCC Othello Clinic with the OBCC team and community.

1.26.22

Dr. André Dick is appointed Seattle Children’s senior vice president (SVP) and surgeon-in-chief, Bonnie Fryzlewicz is appointed SVP and chief nursing officer and Dr. Jeff Ojemann is appointed SVP and chief medical officer.

12.9.21

When Seattle Children’s committed to becoming an anti-racist organization, we made a commitment to listen and make changes. Today Seattle Children’s is releasing the first Health Equity and Anti-Racism Action Plan quarterly report.

12.1.21

Seattle Children’s presented at the American Society of Hematology annual meeting, the world’s premier event in malignant and non-malignant hematology, in Dec. 2021. These studies demonstrate the depth and breadth of research in pediatric blood cancer within Seattle Children's.

9.1.21

Seattle Children's releases our Health Equity and Anti-Racism Action Plan based on the Assessment Committee’s work with Covington & Burling LLP.

9.1.21

Jeff Sperring, MD, CEO, shares Seattle Children’s Health Equity and Anti-Racism Action Plan in response to the recommendations Covington & Burling outlined in their independent assessment of Seattle Children’s efforts to dismantle racism and promote diversity, equity and inclusion.

8.9.21

In line with the Assessment Committee’s recommendations and our community’s requests, the Seattle Children’s Hospital Board of Trustees voted unanimously to release Covington’s findings and recommendations, which will be used as a roadmap to guide the action plan Task Force.

7.30.21

A direct communication about the independent assessment of Seattle Children’s efforts to combat racism and promote diversity, equity and inclusion led by Former U.S. Attorney General Eric Holder of the Covington law firm.

7.22.21

Seattle Children’s is excited to announce results published today in JAMA Oncology.

7.13.21

Fred Hutchinson Cancer Research Center, UW Medicine, Seattle Cancer Care Alliance and Seattle Children’s are exploring a comprehensive collaboration aimed at bringing groundbreaking research to patient care for children and adults

5.5.21

Seattle Children's today announced that Anu and Satya Nadella and their family have generously committed $15 million to advance precision medicine neurosciences and youth mental health care at Seattle Children's, and to help provide equitable access to care for every family and community.

4.21.21

A message from Bonnie Fryzlewicz, Vice President and Chief Nursing Officer for Seattle Children’s

3.19.21

A letter from Seattle Children’s Leadership team addressing increasing acts of violence, xenophobia and hate against Asian and Pacific Islander communities, and this week’s shootings in the Atlanta area.

2.3.21

It has been our deeply held value and commitment at Seattle Children’s to provide a place where every child and family member feels valued, safe and seen and where Seattle Children’s workforce feels respected and valued.

1.30.21

Statement from The Seattle Children’s Assessment Committee

1.14.21

New community and board trustee members named to Assessment Committee

1.6.21

New board committee formed, will include community members and independent outside expert

12.15.20

Today, Seattle Children’s received its first doses of Pfizer’s COVID-19 vaccine and will deploy its allocation in phases based on guidelines from the Centers for Disease Control and Prevention.

9.24.20

We frequently test the air in every OR and can confirm the operating rooms at Seattle Children’s are safe.

8.5.20

Announces exclusive licensing partnerships for proprietary regulatory T cell engineering technologies with Seattle Children's Research Institute, Benaroya Research Institute and MIGAL Galilee Research Institute

6.2.20

Initially, the alliance will develop treatment options for patients with two rare, life-threatening primary immunodeficiency diseases – Wiskott-Aldrich Syndrome (WAS) and X-linked Agammaglobulinemia (XLA)

{dateline}

{teaser}